New treatments for men with castration-resistant prostate cancer: can we move from small steps to giant leaps?
Duke Cancer Institute and the Duke Prostate Center, Duke University, DUMC Box 102002, Durham, NC 27710, USA. Electronic address: andrew.armstrong@duke.edu.
Andrew J
AJ
Armstrong
D000818:Animals; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D008297:Male; D064129:Prostatic Neoplasms, Castration-Resistant / Q000628:therapy*; D019275:Radiopharmaceuticals / Q000627:therapeutic use*
D018931:Antineoplastic Agents, Hormonal; D019275:Radiopharmaceuticals